| Symbol |
Name |
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
ALPK2
|
alpha-kinase 2
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCR
|
breakpoint cluster region
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CLK1
|
CDC-like kinase 1
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
|
CSMD3
|
CUB and Sushi multiple domains 3
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DCLK3
|
doublecortin-like kinase 3
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DST
|
dystonin
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
EDN1
|
endothelin 1
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EPHA6
|
EPH receptor A6
|
|
EPHA8
|
EPH receptor A8
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FGFR1OP
|
FGFR1 oncogene partner
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FN1
|
fibronectin 1
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILK
|
integrin-linked kinase
|
|
IRF4
|
interferon regulatory factor 4
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
LASP1
|
LIM and SH3 protein 1
|
|
MAML3
|
mastermind-like 3 (Drosophila)
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1
|
|
MAST1
|
microtubule associated serine/threonine kinase 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIEN1
|
migration and invasion enhancer 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NAV3
|
neuron navigator 3
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NEK3
|
NIMA-related kinase 3
|
|
NFIA
|
nuclear factor I/A
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
PAX3
|
paired box 3
|
|
PCDH15
|
protocadherin-related 15
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PPM1E
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STK31
|
serine/threonine kinase 31
|
|
TCF21
|
transcription factor 21
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TMEM123
|
transmembrane protein 123
|
|
TNRC6B
|
trinucleotide repeat containing 6B
|
|
TP63
|
tumor protein p63
|
|
TRIM42
|
tripartite motif containing 42
|
|
TTBK1
|
tau tubulin kinase 1
|
|
TTN
|
titin
|
|
VEGFC
|
vascular endothelial growth factor C
|